Pediatric traumatic brain injury and early age multiple sclerosis in Finland: a nationwide register-based cohort study - Laaksonen J, Ponkilainen V, Kuitunen I, M öttönen J, Mattila VM.
OBJECTIVE: Examine the link between pediatric traumatic brain injury (pTBI) and early-onset multiple sclerosis in Finland. METHODS: Conducted nationwide register study (1998-2018) with 28,750 pTBI patients (... (Source: SafetyLit)
Source: SafetyLit - April 18, 2024 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Roche ’s subcutaneous OCREVUS one-year data demonstrates near-complete suppression of clinical relapses and brain lesions in patients with progressive and relapsing forms of MS
Results from the Phase III study showed that subcutaneous (SC) injection was consistent with IV infusion and demonstrated near-complete suppression of relapse activity (97%) and MRI lesions (97.2%) through 48 weeksThe twice-yearly, 10-minute SC injection has the potential to expand the usage of OCREVUS to treatment centres without IV infrastructure or with IV capacity limitationsU.S. FDA and EMA accepted filings based on the data from OCARINA II, with EU approval anticipated mid-2024 and U.S. approval anticipated September 2024Basel, 17 April 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today data from the Phase III...
Source: Roche Media News - April 17, 2024 Category: Pharmaceuticals Source Type: news
High-Efficacy Therapy Cuts Disability Progression in Pediatric MS
FRIDAY, April 12, 2024 -- Treatment of pediatric-onset relapsing-remitting multiple sclerosis with high-efficacy therapy reduces the risk for transition across disability states, according to a study published in the May issue of The Lancet Child... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 12, 2024 Category: Pharmaceuticals Source Type: news
Is there anything Ozempic can't do? Now weight-loss drug is said to lower chance of MS and could help sleep apnea - despite 100 US deaths linked to the injections
In the latest round of studies, doctors suggested the blockbuster medication - behind a now $80billion market - could lower the risk of multiple sclerosis (MS) by up to 80 percent and even ease sleep apnea in patients. (Source: the Mail online | Health)
Source: the Mail online | Health - April 9, 2024 Category: Consumer Health News Source Type: news
Conference MDAngle: AAN 2024: Relapsing-Remitting Multiple Sclerosis (RRMS) Conference MDAngle: AAN 2024: Relapsing-Remitting Multiple Sclerosis (RRMS)
Dr Michael Sy previews treatments, biomarkers, and strategies for ensuring equitable access to care to be presented at AAN 2024.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 8, 2024 Category: Consumer Health News Tags: None MDAngle Source Type: news
Traumatic brain injury, race, ethnicity and cognition in newly diagnosed persons with multiple sclerosis - Akinsanya J, Smith JB, Langer-Gould A.
We sought to determine whether a history of traumatic brain injury (TBI) could explain the lower symbol digit modalities test (SDMT) scores observed among newly diagnosed multiple sclerosis (MS) and control participants identifying as Black or Hispanic ver... (Source: SafetyLit)
Source: SafetyLit - April 8, 2024 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
French-led team unveils 11.7 tesla MRI scans of human brain
A research group based in Saclay, near Paris, has taken the wraps off what it claims are the world's first MRI scans of the human brain in vivo taken at a field strength of 11.7 tesla. President Emmanuel Macron has congratulated the researchers on social media.
"The first images surpassed our expectations, giving after just four minutes, mind-blowing brain images without any artifacts, with superb tissue contrast and resolution, which represents a volume equivalent to a few thousand neurons," Denis Le Bihan, PhD, founding director of the NeuroSpin research facility and founder of Iseult Project of the French Alternative E...
Source: AuntMinnie.com Headlines - April 4, 2024 Category: Radiology Authors: Philip Ward Tags: MRI Source Type: news
She ’s Shaking Up Classical Music While Confronting Illness
The pianist Alice Sara Ott, who makes her New York Philharmonic debut this week, is upending concert culture — and defying stereotypes about multiple sclerosis. (Source: NYT Health)
Source: NYT Health - April 3, 2024 Category: Consumer Health News Authors: Javier C. Hern ández Tags: Classical Music Multiple Sclerosis New York Philharmonic Ott, Alice Sara Munich (Germany) Content Type: Personal Profile Source Type: news
Multiple Sclerosis and Epstein-Barr Virus: What Do We Know? Multiple Sclerosis and Epstein-Barr Virus: What Do We Know?
Research suggested that EBV is the primary cause of MS. What are the clinical implications, and could this transform treatment and prevention of this neurodegenerative condition?Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 2, 2024 Category: Allergy & Immunology Tags: Neurology & Neurosurgery Source Type: news
Risk factors for psychiatric disorders in patients with multiple sclerosis-a single-center study in the polish population - Mado H, B łachut M, Szczegielniak A, Świerzy K, Zając M, Kubicka-Bączyk K, Gorczyca P, Adamczyk-Sowa M.
AIM: The aim of this study was to determine the prevalence of mental disorders in a group of patients with multiple sclerosis (MS) during outpatient treatment. Additionally, an attempt was made to assess the influence of parameters related to patients and ... (Source: SafetyLit)
Source: SafetyLit - March 30, 2024 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
First-in-Disease Use of Kyverna Therapeutics' KYV-101 in Patients With Progressive Multiple Sclerosis Published in Med
Two patients were treated with KYV-101, a fully human anti-CD19 CAR T-cell product candidate, in Germany as part of a named patient program after failure to respond to conventional therapies The treatment resulted in an acceptable safety profile, with no observed clinical signs of early... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 29, 2024 Category: Pharmaceuticals Tags: TRI Source Type: news
Improving Quality of Life in MS: Psychological Strategies Improving Quality of Life in MS: Psychological Strategies
Dr Frederick Foley shares key approaches for enhancing emotional well-being in patients with multiple sclerosis.Consortium of Multiple Sclerosis Centers (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 29, 2024 Category: Neurology Tags: Neurology & Neurosurgery Commentary Source Type: news
Obesity in Childhood Doubles Odds for MS in Young Adulthood
FRIDAY, March 29, 2024 -- Children who are obese face double the odds of developing multiple sclerosis later in life, a new study warns.The overall odds for any one child to develop the neurodegenerative illness remains very low. However, the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 29, 2024 Category: General Medicine Source Type: news
Obese children twice as likely to develop multiple sclerosis, study suggests
Swedish researchers say inflammation caused by obesity is likely to increase risk of developing conditions such as MSChildren who are obese may face more than double the risk of developing multiple sclerosis as adults, a study suggests.MS can affect the brain and spinal cord, causing a range of potential symptoms including problems with vision, arm or leg movement, sensation or balance. It is a lifelong condition that can sometimes cause serious disability.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - March 28, 2024 Category: Science Authors: Andrew Gregory Health editor Tags: Obesity Multiple sclerosis Children's health Society Medical research Science Source Type: news
The virus that infects almost everyone, and its link to cancer and MS – podcast
On 28 March it ’s the 60th anniversary of the discovery of Epstein-Barr virus, the most common viral infection in humans. The virus was first discovered in association with a rare type of cancer located in Africa, but is now understood to be implicated in 1% of cancers, as well as the autoimmune disease multiple sclerosis, among others. Ian Sample meets Lawrence Young, professor of molecular oncology at Warwick Medical School, to hear the story of this virus, and how understanding it might help us prevent and treat cancer and other illnesses.Read an obituary of Sir Anthony Epstein, who died in February 2024Continue readi...
Source: Guardian Unlimited Science - March 28, 2024 Category: Science Authors: Presented by Ian Sample, produced by Holly Fisher and Madeleine Finlay, sound design by Tony Onuchukwu, the executive producer is Ellie Bury Tags: Science Cancer research Medical research Multiple sclerosis UK news Source Type: news
